Cellectis (CLLS) EBITDA (2015 - 2026)
Cellectis (CLLS) posted quarterly EBITDA of -$25.2 million for Q1 2026, down 77.49% year-over-year from -$111.8 million in Q1 2025, and down 45.04% quarter-over-quarter from -$17.4 million in Q4 2025.
Cellectis (CLLS) EBITDA (2015 - 2026) Analysis & Trends
Cellectis' EBITDA history runs 12 years deep, the most recent figure standing at -$25.2 million for Q1 2026.
- In Q1 2026, EBITDA fell 77.49% year-over-year to -$25.2 million; the TTM figure through Mar 2026 stood at -$44.1 million (up 16.61% YoY), while the FY2025 annual figure was -$59.6 million, changed 0.0% from the prior year.
- EBITDA for Q1 2026 stood at -$25.2 million, down from -$17.4 million in the prior quarter.
- The five-year high for EBITDA was $8.0 million in Q3 2025, with the low at -$29.6 million in Q4 2023.
- The 5-year median for EBITDA is -$20.7 million (2023), against an average of -$17.9 million.
- The sharpest annual moves came in 2023 and 2025: EBITDA tumbled 422.6% in 2023, then jumped 174.67% in 2025.
- Cellectis' EBITDA stood at -$5.7 million in 2022, then sank by 422.6% to -$29.6 million in 2023, then surged by 63.89% to -$10.7 million in 2024, then plunged by 62.47% to -$17.4 million in 2025, then slumped by 45.04% to -$25.2 million in 2026.
- Business Quant data shows CLLS's EBITDA at -$25.2 million in Q1 2026, -$17.4 million in Q4 2025, and $8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | -25.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.17 Mn |
| Dec 31, 2025 | -17.35 Mn |
| Sep 30, 2025 | 8.04 Mn |
| Jun 30, 2025 | -9.59 Mn |
| Mar 31, 2025 | -14.18 Mn |
| Dec 31, 2024 | -10.68 Mn |
| Sep 30, 2024 | -10.77 Mn |
| Jun 30, 2024 | -17.21 Mn |
| Mar 31, 2024 | -20.89 Mn |
| Dec 31, 2023 | -29.58 Mn |
| Sep 30, 2023 | -20.67 Mn |
| Jun 30, 2023 | -23.62 Mn |
| Mar 31, 2023 | -23.43 Mn |
| Dec 31, 2022 | -5.66 Mn |
| Sep 30, 2022 | -27.35 Mn |
| Jun 30, 2022 | -27.31 Mn |
| Mar 31, 2022 | -29.23 Mn |
| Dec 31, 2021 | -24.56 Mn |
| Sep 30, 2021 | -42.37 Mn |
| Jun 30, 2021 | -37.48 Mn |